Formation of the collateral circulation is regulated by vascular endothelial growth factor-a and a disintegrin and metalloprotease family members 10 and 17

Circulation Research

Volumn 111, Issue 12, 2012, Pages 1539-1550

  Lucitti, Jennifer L ^a   MacKey, Jessica K ^a   Morrison, Jeffrey C ^a   Haigh, Jody J ^b,c   Adams, Ralf H ^d   Faber, James E ^a,e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

a disintegrin and metalloprotease; angiogenesis; collateral; embryo; vascular endothelial growth factor

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAM17 PROTEIN; NOTCH1 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BRAIN ARTERY; CELL MIGRATION; CELL PROLIFERATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; COLLATERAL CIRCULATION; GENE KNOCKDOWN TECHNIQUES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84863257459     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.279109     Document Type: Article

References (49)

1. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, Wustmann K, Billinger M, Vogel R, Cook S, Wenaweser P, Togni M, Windecker S, Meier B, Seiler C. Benefcial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116:975-983. (Pubitemid 47329562)
2. Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, Kim D, Jahan R, Duckwiler GR, Yoon SR, Viñuela F, Liebeskind DS; UCLA Collateral Investigators. Impact of collateral fow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatr. 2008;79: 625-629. (Pubitemid 351829431)
3. Brozici M, van der Zwan A, Hillen B. Anatomy and functionality of lep-tomeningeal anastomoses: a review. Stroke. 2003;34:2750-2762. (Pubitemid 37392779)
4. Menon BK, Smith EE, Modi J, Patel SK, Bhatia R, Watson TW, Hill MD, Demchuk AM, Goyal M. Regional leptomeningeal score on CT angiography predicts clinical and imaging outcomes in patients with acute anterior circulation occlusions. AJNR Am J Neuroradiol. 2011;32:1640-1645.
5. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics. 2007;30:179-191. (Pubitemid 47173281)
6. Zhang H, Prabhakar P, Sealock R, Faber JE. Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J Cereb Blood Flow Metab. 2010;30:923-934.
7. Clayton JA, Chalothorn D, Faber JE. Vascular endothelial growth fac-tor-A specifes formation of native collaterals and regulates collateral growth in ischemia. Circ Res. 2008;103:1027-1036.
8. Faber JE, Zhang H, Lassance-Soares RM, Prabhakar P, Najaf AH, Burnett MS, Epstein SE. Aging causes collateral rarefaction and increased severity of ischemic injury in multiple tissues. Arterioscler Thromb Vasc Biol. 2011;31:1748-1756.
9. Schaper W. Collateral circulation: past and present. Basic Res Cardiol. 2009;104:5-21.
10. Schirmer SH, van Nooijen FC, Piek JJ, van Royen N. Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart. 2009;95:191-197.
11. Chalothorn D, Faber JE. Formation and maturation of the native cerebral collateral circulation. J Mol Cell Cardiol. 2010;49:251-259.
12. Damert A, Miquerol L, Gertsenstein M, Risau W, Nagy A. Insuffcient VEGFA activity in yolk sac endoderm compromises haematopoietic and endothelial differentiation. Development. 2002;129:1881-1892. (Pubitemid 34874203)
13. Miquerol L, Langille BL, Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 2000;127:3941-3946.
14. Fernandez B. Embryonic development of collaterals. In: Schaper W, Schaper J, eds. Arteriogenesis. Norwell, MA: Kluwer Academic Publishers; 2004:11-19.
15. Bernatchez PN, Soker S, Sirois MG. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. J Biol Chem. 1999;274:31047-31054.
16. Cai J, Jiang WG, Ahmed A, Boulton M. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res. 2006;71:20-31. (Pubitemid 43175845)
17. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007;130:691-703. (Pubitemid 47268059)
18. Pruessmeyer J, Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, infammation and cancer. Semin Cell Dev Biol. 2009;20:164-174.
19. Bozkulak EC, Weinmaster G. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling. Mol Cell Biol. 2009;29:5679-5695.
20. Bär T, Miodoski A, Budi Santoso AW. Postnatal development of the vascular pattern in the rat telencephalic pia-arachnoid. A SEM study. Anat Embryol. 1986;174:215-223. (Pubitemid 16069787)
21. Zhang L, Zhao Y, Zhou JW. The three-dimensional structure and the relationship between external and internal vascularizations in the brain of rat embryos. Chin Med J. 2004;117:280-285. (Pubitemid 38351458)
22. Wang DB, Blocher NC, Spence ME, Rovainen CM, Woolsey TA. Development and remodeling of cerebral blood vessels and their fow in postnatal mice observed with in vivo videomicroscopy. J Cereb Blood Flow Metab. 1992;12:935-946.
23. Lucitti JL, Jones EA, Huang C, Chen J, Fraser SE, Dickinson ME. Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development. 2007;134:3317-3326. (Pubitemid 350018432)
24. Clark EB, Hu N. Developmental hemodynamic changes in the chick embryo from stage 18 to 27. Circ Res. 1982;51:810-815. (Pubitemid 13217275)
25. Hu N, Clark EB. Hemodynamics of the stage 12 to stage 29 chick embryo. Circ Res. 1989;65:1665-1670. (Pubitemid 20023559)
26. Buschmann I, Pries A, Styp-Rekowska B, et al. Pulsatile shear and Gja5 modulate arterial identity and remodeling events during fow-driven ar-teriogenesis. Development. 2010;137:2187-2196.
27. Othman-Hassan K, Patel K, Papoutsi M, Rodriguez-Niedenführ M, Christ B, Wilting J. Arterial identity of endothelial cells is controlled by local cues. Dev Biol. 2001;237:398-409. (Pubitemid 32881130)
28. Reinert RB, Kantz J, Misfeldt AA, Poffenberger G, Gannon M, Brissova M, Powers AC. Tamoxifen-induced cre-loxP recombination is prolonged in pancreatic islets of adult mice. PLoS ONE. 2012;7:e33529.
29. Vogel J, Gehrig M, Kuschinsky W, Marti HH. Massive inborn angiogen-esis in the brain scarcely raises cerebral blood fow. J Cereb Blood Flow Metab. 2004;24:849-859. (Pubitemid 39045402)
30. Heinzer S, Kuhn G, Krucker T, Meyer E, Ulmann-Schuler A, Stampanoni M, Gassmann M, Marti HH, Müller R, Vogel J. Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF(165) in the brain. Neuroimage. 2008;39:1549-1558.
31. Wang Y, Kilic E, Kilic U, Weber B, Bassetti CL, Marti HH, Hermann DM. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain. 2005;128:52-63. (Pubitemid 40070520)
32. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, Betsholtz C, Shima DT. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 2002;16:2684-2698.
33. De Smet F, Segura I, De Bock K, Hohensinner PJ, Carmeliet P. Mechanisms of vessel branching: flopodia on endothelial tip cells lead the way. Arterioscler Thromb Vasc Biol. 2009;29:639-649.
34. Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis. 2008;4:241-246.
35. Henderson AM, Wang SJ, Taylor AC, Aitkenhead M, Hughes CC. The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation. J Biol Chem. 2001;276:6169-6176.
36. Moya IM, Umans L, Maas E, Pereira PN, Beets K, Francis A, Sents W, Robertson EJ, Mummery CL, Huylebroeck D, Zwijsen A. Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. Dev Cell. 2012;22:501-514.
37. Black RA. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol. 2002;34:1-5. (Pubitemid 33152908)
38. Sunnarborg SW, Hinkle CL, Stevenson M, Russell WE, Raska CS, Peschon JJ, Castner BJ, Gerhart MJ, Paxton RJ, Black RA, Lee DC. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem. 2002;277:12838-12845. (Pubitemid 34952648)
39. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, Patterson C, Lee DC. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 2003;22: 2704-2716. (Pubitemid 36712367)
40. Peschon JJ, Slack JL, Reddy P, et al. An essential role for ectodo-main shedding in mammalian development. Science. 1998;282: 1281-1284. (Pubitemid 28524483)
41. Kwak HI, Mendoza EA, Bayless KJ. ADAM17 co-purifes with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices. Matrix Biol. 2009;28:470-479.
42. Canault M, Certel K, Schatzberg D, Wagner DD, Hynes RO. The lack of ADAM17 activity during embryonic development causes hemorrhage and impairs vessel formation. PLoS ONE. 2010;5:e13433.
43. Swendeman S, Mendelson K, Weskamp G, Horiuchi K, Deutsch U, Scherle P, Hooper A, Rafi S, Blobel CP. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ Res. 2008;103:916-918.
44. Weskamp G, Mendelson K, Swendeman S, Le Gall S, Ma Y, Lyman S, Hinoki A, Eguchi S, Guaiquil V, Horiuchi K, Blobel CP. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res. 2010;106:932-940.
45. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lübke T, Lena Illert A, von Figura K, Saftig P. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fbroblasts. Hum Mol Genet. 2002;11:2615-2624. (Pubitemid 35174691)
46. Donners MM, Wolfs IM, Olieslagers S, Mohammadi-Motahhari Z, Tchaikovski V, Heeneman S, van Buul JD, Caolo V, Molin DG, Post MJ, Waltenberger J. A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30:2188-2195.
47. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, Reiss K. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res. 2008;102:1192-1201.
48. Glomski K, Monette S, Manova K, De Strooper B, Saftig P, Blobel CP. Deletion of Adam10 in endothelial cells leads to defects in organ-specifc vascular structures. Blood. 2011;118:1163-1174.
49. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, Wilson SW, Ruhrberg C. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood. 2010;116:829-840.